[HTML][HTML] From diagnosis to treatment of hepatocellular carcinoma: An epidemic problem for both developed and developing world
D Dimitroulis, C Damaskos, S Valsami… - World journal of …, 2017 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is the most frequent primary liver malignancy and the third
cause of cancer-related death in the Western Countries. The well-established causes of …
cause of cancer-related death in the Western Countries. The well-established causes of …
[HTML][HTML] 68Ga-FAPI-04 Versus 18F-FDG PET/CT in the Detection of Hepatocellular Carcinoma
H Wang, W Zhu, S Ren, Y Kong, Q Huang… - Frontiers in …, 2021 - frontiersin.org
Background Fibroblast activation protein (FAP) is commonly expressed in activated stromal
fibroblasts in various epithelial tumours. Recently, 68Ga-FAPI-04 has been used for tumour …
fibroblasts in various epithelial tumours. Recently, 68Ga-FAPI-04 has been used for tumour …
PET parametric imaging: past, present, and future
Positron emission tomography (PET) is actively used in a diverse range of applications in
oncology, cardiology, and neurology. The use of PET in the clinical setting focuses on static …
oncology, cardiology, and neurology. The use of PET in the clinical setting focuses on static …
[HTML][HTML] Hepatocellular carcinoma: consensus recommendations of the national cancer institute clinical trials planning meeting
MB Thomas, D Jaffe, MM Choti, J Belghiti… - Journal of clinical …, 2010 - ncbi.nlm.nih.gov
Hepatocelluar carcinoma (HCC) is the most common primary malignancy of the liver in
adults and the third most common cause of cancer death worldwide. The incidence of HCC …
adults and the third most common cause of cancer death worldwide. The incidence of HCC …
New approaches for imaging tumour responses to treatment
K Brindle - Nature Reviews Cancer, 2008 - nature.com
Tumour responses to treatment are still largely assessed from imaging measurements of
reductions in tumour size. However, this can take several weeks to become manifest and in …
reductions in tumour size. However, this can take several weeks to become manifest and in …
Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis and therapeutics
Hepatocellular carcinoma (HCC) is the third most common cause of cancer-related death
worldwide and, owing to changes in the prevalence of the two major risk factors, hepatitis B …
worldwide and, owing to changes in the prevalence of the two major risk factors, hepatitis B …
Multiplexed imaging for diagnosis and therapy
Complex molecular and metabolic phenotypes depict cancers as a constellation of different
diseases with common themes. Precision imaging of such phenotypes requires flexible and …
diseases with common themes. Precision imaging of such phenotypes requires flexible and …
A prospective evaluation of 18F-FDG and 11C-acetate PET/CT for detection of primary and metastatic hepatocellular carcinoma
Because 18F-FDG PET has insufficient sensitivity for the detection of hepatocellular
carcinoma (HCC), 11C-acetate PET has been proposed as another technique for this use …
carcinoma (HCC), 11C-acetate PET has been proposed as another technique for this use …
[HTML][HTML] Imaging of hepatocellular carcinoma: diagnosis, staging and treatment monitoring
T Hennedige, SK Venkatesh - Cancer Imaging, 2012 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is the most common primary liver cancer. Imaging is
important for establishing a diagnosis of HCC. Several imaging modalities including …
important for establishing a diagnosis of HCC. Several imaging modalities including …